199 related articles for article (PubMed ID: 17804698)
1. Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic.
Obeid M; Panaretakis T; Tesniere A; Joza N; Tufi R; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G
Cancer Res; 2007 Sep; 67(17):7941-4. PubMed ID: 17804698
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
Chaput N; De Botton S; Obeid M; Apetoh L; Ghiringhelli F; Panaretakis T; Flament C; Zitvogel L; Kroemer G
J Mol Med (Berl); 2007 Oct; 85(10):1069-76. PubMed ID: 17891368
[TBL] [Abstract][Full Text] [Related]
3. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
4. The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure.
Molinari R; D'Eliseo D; Manzi L; Zolla L; Velotti F; Merendino N
Cancer Immunol Immunother; 2011 Oct; 60(10):1503-7. PubMed ID: 21779875
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.
Zitvogel L; Kepp O; Senovilla L; Menger L; Chaput N; Kroemer G
Clin Cancer Res; 2010 Jun; 16(12):3100-4. PubMed ID: 20421432
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis.
Fredly H; Ersvær E; Gjertsen BT; Bruserud O
Oncol Rep; 2011 Jun; 25(6):1549-56. PubMed ID: 21431284
[TBL] [Abstract][Full Text] [Related]
7. Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.
Hannani D; Locher C; Yamazaki T; Colin-Minard V; Vetizou M; Aymeric L; Viaud S; Sanchez D; Smyth MJ; Bruhns P; Kroemer G; Zitvogel L
Cell Death Differ; 2014 Jan; 21(1):50-8. PubMed ID: 23744294
[TBL] [Abstract][Full Text] [Related]
8. Calreticulin exposure dictates the immunogenicity of cancer cell death.
Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Apetoh L; Perfettini JL; Castedo M; Mignot G; Panaretakis T; Casares N; Métivier D; Larochette N; van Endert P; Ciccosanti F; Piacentini M; Zitvogel L; Kroemer G
Nat Med; 2007 Jan; 13(1):54-61. PubMed ID: 17187072
[TBL] [Abstract][Full Text] [Related]
9. Late-stage inhibition of autophagy enhances calreticulin surface exposure.
Li DD; Xie B; Wu XJ; Li JJ; Ding Y; Wen XZ; Zhang X; Zhu SG; Liu W; Zhang XS; Peng RQ
Oncotarget; 2016 Dec; 7(49):80842-80854. PubMed ID: 27825129
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic cell death modalities and their impact on cancer treatment.
Kepp O; Tesniere A; Schlemmer F; Michaud M; Senovilla L; Zitvogel L; Kroemer G
Apoptosis; 2009 Apr; 14(4):364-75. PubMed ID: 19145485
[TBL] [Abstract][Full Text] [Related]
11. Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.
Zappasodi R; Pupa SM; Ghedini GC; Bongarzone I; Magni M; Cabras AD; Colombo MP; Carlo-Stella C; Gianni AM; Di Nicola M
Cancer Res; 2010 Nov; 70(22):9062-72. PubMed ID: 20884630
[TBL] [Abstract][Full Text] [Related]
12. Effects of chemoradiation on tumor-host interactions: the immunologic side.
Formenti SC; Demaria S
J Clin Oncol; 2008 Mar; 26(9):1562-3; author reply 1563. PubMed ID: 18349411
[No Abstract] [Full Text] [Related]
13. Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative Stress.
Lin A; Truong B; Patel S; Kaushik N; Choi EH; Fridman G; Fridman A; Miller V
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467380
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A; Apetoh L; Ghiringhelli F; Joza N; Panaretakis T; Kepp O; Schlemmer F; Zitvogel L; Kroemer G
Curr Opin Immunol; 2008 Oct; 20(5):504-11. PubMed ID: 18573340
[TBL] [Abstract][Full Text] [Related]
15. Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model.
Gomez-Cadena A; Urueña C; Prieto K; Martinez-Usatorre A; Donda A; Barreto A; Romero P; Fiorentino S
Cell Death Dis; 2016 Jun; 7(6):e2243. PubMed ID: 27253407
[TBL] [Abstract][Full Text] [Related]
16. Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death.
Kepp O; Gdoura A; Martins I; Panaretakis T; Schlemmer F; Tesniere A; Fimia GM; Ciccosanti F; Burgevin A; Piacentini M; Eggleton P; Young PJ; Zitvogel L; van Endert P; Kroemer G
Cell Cycle; 2010 Aug; 9(15):3072-7. PubMed ID: 20699648
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic Apoptotic Cell Death and Anticancer Immunity.
Vandenabeele P; Vandecasteele K; Bachert C; Krysko O; Krysko DV
Adv Exp Med Biol; 2016; 930():133-49. PubMed ID: 27558820
[TBL] [Abstract][Full Text] [Related]
18. Calreticulin Exposure in Mitotic Catastrophe.
Bezu L; Kepp O; Kroemer G
Methods Mol Biol; 2021; 2267():207-215. PubMed ID: 33786794
[TBL] [Abstract][Full Text] [Related]
19. Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death.
Qin J; Kunda N; Qiao G; Calata JF; Pardiwala K; Prabhakar BS; Maker AV
Cell Death Dis; 2017 Feb; 8(2):e2584. PubMed ID: 28151483
[TBL] [Abstract][Full Text] [Related]
20. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
